Agitation and aggression in adult psychiatric patients with psychoses and in persons with dementia increase the burden of disease and frequently cause hospitalization. The implementation of currently available management strategies and the development of new ones is hindered by inconsistent terminology that confuses agitation with aggression. This confusion is maintained by many rating scales that fail to distinguish between these two syndromes. We review the frequently used rating scales with a particular focus on their ability to separate agitation from aggression. Agitation and aggression are two different syndromes. For example, reactive aggression is often precipitated by rejection of care and may not be associated with agitation per se. We propose, in treatment studies of behavioral symptoms of dementia and challenging behaviors in psychoses, that outcomes should be evaluated separately for agitation and aggression. This is important for investigation of drug effectiveness since the medication may be effective against one syndrome but not the other. Separate assessments of agitation and aggression should be a general principle of trial design with particular salience for registration studies of medications proposed for approval by the U.S. Food and Drug Administration and other regulatory bodies.
- Type
- Review Articles
- Information
- Copyright
- © Cambridge University Press 2017
References
Phillips, VL, Diwan, S. The incremental effect of dementia-related problem behaviors on the time to nursing home placement in poor, frail, demented older people. J Am Geriatr Soc. 2003; 51: 188–193.CrossRefGoogle Scholar
Cummings, J, Mintzer, J, Brodaty, H, et al. Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition. Int Psychogeriatr. 2015; 27(1): 7–17. Epub ahead of print Oct 14, 2014. https://www.ncbi.nlm.nih.gov
Merriam Webster Dictionary. http://www.merriam-webster.com
Lindenmayer, JP. The pathophysiology of agitation. J Clin Psychiatry. 2000; 61(Suppl. 14): 5–10.Google Scholar
Citrome, L, Volavka, J. Treatment of violent behavior. In: Tasman A, Kay J, Lieberman JA, eds. Psychiatry, 2nd ed. Chichester: John Wiley & Sons; 2003: P. 2136–2146.Google ScholarPubMed
Hurley, AC, Volicer, L, Camberg, L, et al. Measurement of observed agitation in patients with Alzheimer’s disease. J Mental Health Aging. 1999; 5: 117–133.Google Scholar
Volavka, J. Neurobiology of Violence, 2nd ed. Washington, DC: American Psychiatric Publishing; 2002.Google Scholar
Gardner, KJ, Archer, J, Jackson, S. Does maladaptive coping mediate the relationship between borderline personality traits and reactive and proactive aggression? Aggress Behav. 2012; 38(5): 403–413. Epub ahead of print Jun 18.CrossRefGoogle ScholarPubMed
Miller, JD, Lynam, DR. Reactive and proactive aggression: similarities and differences. Pers Individ Dif. 2006; 41: 1469–1480. https://pdfs.semanticscholar.org
Nolan, KA, Czobor, P, Roy, BB, et al. Characteristics of assaultive behavior among psychiatric inpatients. Psychiatr Serv. 2003; 54(7): 1012–1016. http://ps.psychiatryonline.org
Ryden, MB, Bossenmaier, M, McLachlan, C. Aggressive behavior in cognitively impaired nursing home residents. Res Nurs Health. 1991; 14(2): 87–95.CrossRefGoogle ScholarPubMed
Mahoney, EK, Hurley, AC, Volicer, L, et al. Development and testing of the Resistiveness to Care Scale. Res Nurs Health. 1999; 22(1): 27–38.3.0.CO;2-T>CrossRefGoogle ScholarPubMed
van der Linde, RM, Blossom, CM, Dening, T, Brayne, C. Instruments to measure behavioural and psychological symptoms of dementia. Int J Methods Psychiatr Res. 2014; 23(1): 69–98. Epub ahead of print Feb 5.CrossRefGoogle ScholarPubMed
National Institute of Mental Health. CGI: Clinical Global Impressions. In: Guy W, ed. Manual for the ECDEU Assessment Battery. Chevy Chase, MD: National Institute of Mental Health; 1970: P. 12–16.Google Scholar
Meehan, K, Zhang, F, David, S, et al. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. Clin Psychopharmacol. 2001; 21(4): 389–397.CrossRefGoogle ScholarPubMed
Swift, RH, Harrigan, EP, Cappelleri, JC, Kramer, D, Chandler, LP. Validation of the behavioural activity rating scale (BARS): a novel measure of activity in agitated patients. J Psychiatr Res. 2002; 36(2): 87–95.CrossRefGoogle ScholarPubMed
Volavka, J, Swanson, JW, Citrome, LL. Understanding and managing violence in schizophrenia. In: Lieberman JA, Murray RM, eds. Comprehensive Care of Schizophrenia: A Textbook of Clinical Management, 2nd ed. New York: Oxford University Press; 2012: P. 262–290.Google Scholar
Lieberman, JA, Stroup, TS, McEvoy, JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005; 353(12): 1209–1223. Epub ahead of print Sep 19. http://www.nejm.org
Steadman, HJ, Mulvey, EP, Monahan, J, et al. Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods. Arch Gen Psychiatry. 1998; 55(5): 393–401. http://jamanetwork.com
Swanson, JW, Swartz, MS, Van Dorn, RA, et al. A national study of violent behavior in persons with schizophrenia. Arch Gen Psychiatry. 2006; 63(5): 490–499. http://jamanetwork.com
Citrome, L, Volavka, J, Czobor, P, et al. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. Psychiatr Serv. 2001; 52(11): 1510–1514. http://ps.psychiatryonline.org
Volavka, J, Czobor, P, Nolan, K, et al. Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychopharmacol. 2004; 24(2): 225–228.CrossRefGoogle Scholar
Kay, SR, Sevy, S. Pyramidical model of schizophrenia. Schizophr Bull. 1990; 16(3): 537–545.CrossRefGoogle ScholarPubMed
Montoya, A, Valladares, A, Lizan, L, San, L, Escobar, R, Paz, S. Validation of the exrefd component of the Positive and Negative Syndrome Scale (PANSS–EC) in a naturalistic sample of 278 patients with acute psychosis and agitation in a psychiatric emergency room. Health Qual Life Outcomes. 2011; 9: 18. https://www.ncbi.nlm.nih.gov
Huber, CG, Hochstrasser, L, Meister, K, Schimmelmann, BG, Lambert, M. Evidence for an agitated-aggressive syndrome in early-onset psychosis correlated with antisocial personality disorder, forensic history, and substance use disorder. Schizophr Res. 2016; 175(1–3): 198–203. Epub ahead of print Apr 23.CrossRefGoogle ScholarPubMed
Cohen–Mansfield, J, Marx, MS, Rosenthal, AS. A description of agitation in a nursing home. J Gerontol. 1989; 44(3): M77–M84.CrossRefGoogle Scholar
Koss, E, Weiner, M, Ernesto, C. Assessing patterns of agitation in Alzheimer’s disease patients with the Cohen–Mansfield Agitation Inventory. The Alzheimer’s Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997; 11(Suppl. 2): S45–S50.CrossRefGoogle Scholar
Cohen–Mansfield, J. Instruction Manual for the Cohen–Mansfield Agitation Inventory (CMAI). Rockville, MD: Cohen–Mansfield; 1991. https://shine-dementia.wikispaces.com
Cummings, JL, Mega, M, Gray, K, Rosenberg-Thompson, S, Carusi, DA, Gornbein, J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994; 44(12): 2308–2314.CrossRefGoogle ScholarPubMed
Neuropsychiatric Inventory: Setting the Standard for Alzheimer Research (NPI). http://npitest.net
Aalten, P, Verhey, FR, Boziki, M, et al. Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium, part II. Dementia Geriatr Cogn Disord. 2008; 25(1): 1–8. Epub ahead of print Nov 15, 2007.CrossRefGoogle ScholarPubMed
Nagata, M, Shinagawa, S, Nakajima, S, et al. Classification of neuropsychiatric symptoms requiring antipsychotic treatment in patients with Alzheimer’s disease: analysis of the CATIE–AD Study. J Alzheimers Dis. 2016; 50(3): 839–845.CrossRefGoogle Scholar
Volicer, L, Hurley, A. Agitation in dementia. In: Assessment Scales for Advanced Dementia. London: Health Profession Press; 2015: P. 149–184.Google Scholar
Williams, KN, Hermann, B, Gajweski, B, Wilson, K. Elderspeak communication: impact on dementia care. Am J Alzheimers Dis Other Demen. 2009; 24(1): 11–20. Epub ahead of print Jun 30, 2008. https://www.ncbi.nlm.nih.gov
Hammar, LM, Emami, A, Gottel, E, Engstrom, G. The impact of caregivers’ singing on expressions of emotion and resistance during morning care situations in persons with dementia: an intervention in dementia care. J Clin Nurs. 2011; 20(7–8): 969–978. Epub ahead of print Feb 10.CrossRefGoogle Scholar
Volicer, L, Hurley, A. Rejection of care in dementia. Assessment Scales for Advanced Dementia. London: Health Professions Press; 2015. P. 185–214.Google Scholar
Brown, GL, Goodwin, FK, Ballenger, JC, Goyer, PF, Major, LF. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979; 1(2): 131–139.CrossRefGoogle ScholarPubMed
Coccaro, EF, Berman, ME, Kavoussi, RJ. Assessment of life history of aggression: development and psychometric characteristics. Psychiatry Res. 1997; 73(3): 147–157.CrossRefGoogle ScholarPubMed
Citrome, L. Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. J Clin Psychiatry. 2007; 68(12): 1876–1885.CrossRefGoogle ScholarPubMed
Citrome, L. Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents. Ther Clin Risk Manag. 2013; 9: 235–245. Epub ahead of print May 20. https://www.ncbi.nlm.nih.gov
Citrome, L, Volavka, J. Preventing violence in patients with schizophrenia. Curr Treat Options Psychiatry. 2015; 2: 182–191.CrossRefGoogle Scholar
Volicer, L, Bass, EA, Luther, SL. Agitation and resistiveness to care are two separate behavioral syndromes of dementia. J Am Med Dir Assoc. 2007; 8(8): 527–532.CrossRefGoogle Scholar
Volicer, L, Frijters, DH, van der Steen, JT. Relationship between symptoms of depression and agitation in nursing home residents with dementia. Int J Geriatr Psychiatry. 2012; 27(7): 749–754. Epub ahead of print Sep 28, 2001.CrossRefGoogle ScholarPubMed
Galindo-Garre, F, Volicer, L, van der Steen, JT. Factors related to rejection of care and behaviors directed towards others: a longitudinal study in nursing home residents with dementia. Dement Geriatr Cogn Dis Extra. 2015; 5(1): 123–134. https://www.ncbi.nlm.nih.gov
Harris, GT, Varney, GW. A ten-year study of assaults and assaulters on a maximum security psychiatric unit. J Interpers Violence. 1986; 1: 173–191.CrossRefGoogle Scholar
Volicer, L. What is NPI item “agitation/aggression” really measuring? Am J Geriatr Psychiatry. 2011; 19(12): 1046–1047.CrossRefGoogle ScholarPubMed
Cohen–Mansfield, J, Marx, MS, Dakheel-Ali, M, Regier, NG, Thein, K, Freedman, L. Can agitated behavior of nursing home residents with dementia be prevented with the use of standardized stimuli? J Am Geriatr Soc. 2010; 58(8): 1459–1464. Epub ahead of print Jun 23. https://www.ncbi.nlm.nih.gov
Sloane, PD, Honn, VJ, Dwyer, SAR, Wieselquist, J, Cain, C, Meyers, S. Bathing the Alzheimer’s patient in long term care: results and recommendations from three studies. Am J Alzheimers Dis Other Demen. 1995; 70(4): 3–12. http://journals.sagepub.com
Volavka, J, Citrome, L. Heterogeneity of violence in schizophrenia and implications for long-term treatment. Int J Clin Pract. 2008; 62(8): 1237–1241. Epub ahead of print Jun 28.CrossRefGoogle ScholarPubMed
Ballard, C, Corbett, A. Agitation and aggression in people with Alzheimer’s disease. Curr Opin Psychiatry. 2013; 26(3): 252–259.CrossRefGoogle ScholarPubMed
Garay, RP, Citrome, L, Grossberg, GT, Cavero, I, Llorca, PM. Investigational drugs for treating agitation in persons with dementia. Expert Opin Investig Drugs. 2016; 25(8): 973–983. Epub ahead of print Jun 7.CrossRefGoogle ScholarPubMed
Soto, M, Abushakra, S, Cummings, J, et al. Progress in treatment development for neuropsychiatric symptoms in Alzheimer’s disease: focus on agitation and aggression. A report from the EU/US/CTAD Task Force. J Prev Alzheimers Dis. 2015; 2(3): 184–188. https://www.ncbi.nlm.nih.gov
Siem, C, Rantz, M. Operationalizing the MDS 3.0 in the nursing home. J Am Med Dir Assoc. 2013; 14(8): 445–446. Epub ahead of print Apr 6.CrossRefGoogle ScholarPubMed
